Before we get started with our first impression of CES here in Sin City let’s get the most stunning news out first. While visiting the Abbott booth an Abbott representative stated that Libre2 will not be here in the US for another year. This comment came in response to a question asked by an attendee, we just happened to standing next to the guy. Talk about luck but this is Vegas, and should this statement be accurate JPM just got more interesting.
As we have noted before we have no clue as to why the FDA has . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.